脂鯉技術 TTI 深 滬
等待開盤 11-26 09:30:00 美东时间
7.50
-0.170
-2.22%
華盛通- 最 高7.68
- 今 開7.62
- 成交量 159.59万股
- 最 低 7.14
- 昨 收 7.67
- 總市值 10.05亿
- 52周最高 8.35
- 市盈率 靜 9.16
- 換手率 1.19%
- 52周最低 2.0335
- 委 比 75.00%
- 總股本 1.34亿
- 歷史最高 13.43
- 量 比 0.78
- 振 幅 7.04%
- 歷史最低 0.22
- 每 手 1
- 風險率 1.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tetra Tech三季度盈利超预期，营收增长8.1%
美股周三早盘，多元化石油和天然气服务公司Tetra Technologies（TTI）股价下跌5.6%，此前该公司报告第三季度盈利超预期，营收增长8.1%...
10-29 22:22
Tetra Technologies Raises FY2025 Sales Guidance from $610.000M-$630.000M to $620.000M-$630.000M vs $615.933M Est
Tetra Technologies (NYSE:TTI) raises FY2025 sales outlook from $610.000 million-$630.000 million to $620.000 million-$630.000 million vs $615.933 million estimate.
10-29 05:04
Tetra Technologies Q3 Adj. EPS $0.04 Beats $0.02 Estimate, Sales $153.000M Beat $143.633M Estimate
Tetra Technologies (NYSE:TTI) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 66.67 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the
10-29 05:03
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: Visa (V) W. P. Carey (WPC) Enphase Energy (ENPH) Expand Energy Corporation (EXE) ONEOK (OKE) Other earnings slated for release after Tuesday'...
10-28 22:00
Earnings Scheduled For October 28, 2025
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
10-28 19:11
Tetra Technologies announces Matt Sanderson as new CFO
TETRA Technologies (NYSE:TTI) announced on Monday the appointment of Matt Sanderson as Executive Vice President ("EVP") and CFO. The appointment will be effective post-retirement of Elijio Sennaro, wh...
10-27 20:36
Tetra Technologies Announces CFO Retirement and Successor
Tetra Technologies ( ($TTI) ) just unveiled an update. On October 27, 2025, TET...
10-27 20:29
2025年10月中国翻译公司推荐：译邦达领衔五强
（来源：衡水日报） 转自：衡水日报 在选择中国翻译公司时，关键在于找到最适合自身实际需求的解决方案。中国语言服务市场2024年总产值突破六百亿元，年均复合增长率...
10-16 14:48
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Tvardi Therapeutics Said Preliminary Data From Phase 2 REVERT Trial of TTI-101 In Idiopathic Pulmonary Fibrosis Show That The Study Did Not Meet Its Goals
The REVERT IPF Phase 2 clinical trial was a randomized, double-blind, placebo-controlled clinical trial of TTI-101 alone or in addition to nintedanib (OFEV®) in patients with IPF. The study was designed to assess
10-13 19:32
